• Topics

  • Formats

Organiser: EMJ GOLD

Dr Andreas Konieczny, Vice President and Head of Medical Affairs Europe, ImmunoGen, talks to GOLD about moving from big pharma to biotech, his passion for oncology and lessons in leadership

Interview by Isabel O’Brien

As ImmunoGen’s newly appointed Vice President and Head of Medical Affairs Europe, Dr Andreas Konieczny is beginning a new chapter in his pharmaceutical career.

After about 20 years in the pharma industry and most recently three years at GSK leading the oncology portfolio in Europe, he says he is looking forward to joining a “thriving biotech”, describing it as “the logical next step” in his career.

A trained physician, Konieczny decided to join the industry because he wanted to make a greater difference to the lives of cancer patients by contributing to R&D and providing access to innovative molecules. Nevertheless, the emotional and physical investment by practising treatment teams is something he continues to have a deep respect for.

When not at work, Andreas can be found exploring the great outdoors where he lives in Zug, Switzerland and beyond. “I ride pretty much anything with two wheels and no engine,” he says. Not only is this his favourite way to unwind, but it keeps him focused on his professional passion.

 

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?